Stereotaxis Receives FDA 510(k) Clearance of Vdrive(R) With V-CAS(TM) System Along With Regulatory Approval of Odyssey(R) System in Japan

by Globe Newswire

ST. LOUIS, Jan. 5, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has received 510(k) clearance by the Food and Drug Administration (FDA) for its Vdrive® with V-CAS™ Catheter Advancement System in the U.S., representing the Company's third Vdrive system product to be cleared for market entry. The Company also announced that it has received regulatory approval of its Odyssey® product line by the Japan Pharmaceuticals and Medical Devices Agency, the country's equivalent to the U.S. FDA. 

See the full article here.

Go to kBLASTER for FDA 510(k) predicate search with effective result management to build your successful 510(k) clearance strategy.